Cargando…

Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats

Increased exposure to nicotine contributes to the development of cardiac dysfunction by promoting oxidative stress, fibrosis, and inflammation. These deleterious events altogether render cardiac myocytes more susceptible to acute cardiac insults such as ischemia-reperfusion (I/R) injury. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramalingam, Anand, Budin, Siti Balkis, Mohd. Fauzi, Norsyahida, Ritchie, Rebecca H., Zainalabidin, Satirah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920178/
https://www.ncbi.nlm.nih.gov/pubmed/31920673
http://dx.doi.org/10.3389/fphar.2019.01493
_version_ 1783480893732552704
author Ramalingam, Anand
Budin, Siti Balkis
Mohd. Fauzi, Norsyahida
Ritchie, Rebecca H.
Zainalabidin, Satirah
author_facet Ramalingam, Anand
Budin, Siti Balkis
Mohd. Fauzi, Norsyahida
Ritchie, Rebecca H.
Zainalabidin, Satirah
author_sort Ramalingam, Anand
collection PubMed
description Increased exposure to nicotine contributes to the development of cardiac dysfunction by promoting oxidative stress, fibrosis, and inflammation. These deleterious events altogether render cardiac myocytes more susceptible to acute cardiac insults such as ischemia-reperfusion (I/R) injury. This study sought to elucidate the role of angiotensin II type I (AT1) receptors in cardiac injury resulting from prolonged nicotine administration in a rat model. Male Sprague-Dawley rats were given nicotine (0.6 mg/kg ip) for 28 days to induce cardiac dysfunction, alone or in combination with the AT1 receptor antagonist, irbesartan (10 mg/kg, po). Vehicle-treated rats were used as controls. Rat hearts isolated from each experimental group at study endpoint were examined for changes in function, histology, gene expression, and susceptibility against acute I/R injury determined ex vivo. Rats administered nicotine alone exhibited significantly increased cardiac expression of angiotensin II and angiotensin-converting enzyme (ACE) in addition to elevated systolic blood pressure (SBP) and heart rate. Furthermore, nicotine administration markedly reduced left ventricular (LV) performance with concomitant increases in myocardial oxidative stress, fibrosis, and inflammation. Concomitant treatment with irbesartan attenuated these effects, lowering blood pressure, heart rate, oxidative stress, and expression of fibrotic and inflammatory genes. Importantly, the irbesartan-treated group also manifested reduced susceptibility to I/R injury ex vivo. These findings suggest that AT1 receptors play an important role in nicotine-induced cardiac dysfunction, and pharmacological approaches targeting cardiac AT1 receptors may thus benefit patients with sustained exposure to nicotine.
format Online
Article
Text
id pubmed-6920178
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69201782020-01-09 Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats Ramalingam, Anand Budin, Siti Balkis Mohd. Fauzi, Norsyahida Ritchie, Rebecca H. Zainalabidin, Satirah Front Pharmacol Pharmacology Increased exposure to nicotine contributes to the development of cardiac dysfunction by promoting oxidative stress, fibrosis, and inflammation. These deleterious events altogether render cardiac myocytes more susceptible to acute cardiac insults such as ischemia-reperfusion (I/R) injury. This study sought to elucidate the role of angiotensin II type I (AT1) receptors in cardiac injury resulting from prolonged nicotine administration in a rat model. Male Sprague-Dawley rats were given nicotine (0.6 mg/kg ip) for 28 days to induce cardiac dysfunction, alone or in combination with the AT1 receptor antagonist, irbesartan (10 mg/kg, po). Vehicle-treated rats were used as controls. Rat hearts isolated from each experimental group at study endpoint were examined for changes in function, histology, gene expression, and susceptibility against acute I/R injury determined ex vivo. Rats administered nicotine alone exhibited significantly increased cardiac expression of angiotensin II and angiotensin-converting enzyme (ACE) in addition to elevated systolic blood pressure (SBP) and heart rate. Furthermore, nicotine administration markedly reduced left ventricular (LV) performance with concomitant increases in myocardial oxidative stress, fibrosis, and inflammation. Concomitant treatment with irbesartan attenuated these effects, lowering blood pressure, heart rate, oxidative stress, and expression of fibrotic and inflammatory genes. Importantly, the irbesartan-treated group also manifested reduced susceptibility to I/R injury ex vivo. These findings suggest that AT1 receptors play an important role in nicotine-induced cardiac dysfunction, and pharmacological approaches targeting cardiac AT1 receptors may thus benefit patients with sustained exposure to nicotine. Frontiers Media S.A. 2019-12-12 /pmc/articles/PMC6920178/ /pubmed/31920673 http://dx.doi.org/10.3389/fphar.2019.01493 Text en Copyright © 2019 Ramalingam, Budin, Mohd. Fauzi, Ritchie and Zainalabidin http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ramalingam, Anand
Budin, Siti Balkis
Mohd. Fauzi, Norsyahida
Ritchie, Rebecca H.
Zainalabidin, Satirah
Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats
title Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats
title_full Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats
title_fullStr Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats
title_full_unstemmed Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats
title_short Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats
title_sort angiotensin ii type i receptor antagonism attenuates nicotine-induced cardiac remodeling, dysfunction, and aggravation of myocardial ischemia-reperfusion injury in rats
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920178/
https://www.ncbi.nlm.nih.gov/pubmed/31920673
http://dx.doi.org/10.3389/fphar.2019.01493
work_keys_str_mv AT ramalingamanand angiotensiniitypeireceptorantagonismattenuatesnicotineinducedcardiacremodelingdysfunctionandaggravationofmyocardialischemiareperfusioninjuryinrats
AT budinsitibalkis angiotensiniitypeireceptorantagonismattenuatesnicotineinducedcardiacremodelingdysfunctionandaggravationofmyocardialischemiareperfusioninjuryinrats
AT mohdfauzinorsyahida angiotensiniitypeireceptorantagonismattenuatesnicotineinducedcardiacremodelingdysfunctionandaggravationofmyocardialischemiareperfusioninjuryinrats
AT ritchierebeccah angiotensiniitypeireceptorantagonismattenuatesnicotineinducedcardiacremodelingdysfunctionandaggravationofmyocardialischemiareperfusioninjuryinrats
AT zainalabidinsatirah angiotensiniitypeireceptorantagonismattenuatesnicotineinducedcardiacremodelingdysfunctionandaggravationofmyocardialischemiareperfusioninjuryinrats